{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:48:08Z","timestamp":1792442888748,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.metabol.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T03:32:53Z","timestamp":1494387173000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy"],"prefix":"10.1016","volume":"73","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Koulaxis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4390-3117","authenticated-orcid":false,"given":"Nikoleta","family":"Kefala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagriti","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Pagkalidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Economou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysostomos D.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/BOR.0000000000000337","article-title":"The role of myokines in muscle health and disease","volume":"28","author":"Lightfoot","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0010","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1253\/circj.CJ-16-0663","article-title":"Protective roles of adipocytokines and myokines in cardiovascular disease","volume":"80","author":"Ouchi","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1210\/jc.2014-1367","article-title":"Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet and body composition","volume":"99","author":"Anastasilakis","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.peptides.2013.11.024","article-title":"Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle","volume":"52","author":"Aydin","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0040","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.872200","article-title":"Activin a and follistatin-like 3 determine the susceptibility of heart to ischemic injury","volume":"120","author":"Oshima","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2012.07.064","article-title":"Pathogenesis of acute coronary syndromes","volume":"61","author":"Crea","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.104.483297","article-title":"Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes","volume":"112","author":"Bhatt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2017.05.002_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.peptides.2014.04.002","article-title":"Decreased saliva\/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology","volume":"56","author":"Aydin","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"e72858","DOI":"10.1371\/journal.pone.0072858","article-title":"Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo","volume":"8","author":"Gouni-Berthold","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.metabol.2012.09.002","article-title":"FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise","volume":"61","author":"Huh","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/CIRCHEARTFAILURE.112.969543","article-title":"Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure","volume":"5","author":"Lecker","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"e0136816","DOI":"10.1371\/journal.pone.0136816","article-title":"Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcsm.12006","article-title":"Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines","volume":"6","author":"Matsuo","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.metabol.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"e12419","DOI":"10.14814\/phy2.12419","article-title":"Irisin evokes bradycardia by activating cardiac-projecting neurons of nucleus ambiguus","volume":"3","author":"Brailoiu","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1016\/j.metabol.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"H1501","DOI":"10.1152\/ajpheart.00443.2015","article-title":"Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway","volume":"309","author":"Han","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbrc.2015.11.040","article-title":"Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms","volume":"468","author":"Jiang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjmed.2014.04.025","article-title":"Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity","volume":"127","author":"Emanuele","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.peptides.2014.02.008","article-title":"Irisin: a potentially candidate marker for myocardial infarction","volume":"55","author":"Kuloglu","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2017.05.002_bb0110","first-page":"1567","article-title":"The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study","volume":"18","author":"Zhang","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.metabol.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.10.009","article-title":"The roles of activin a and its binding protein, follistatin, in inflammation and tissue repair","volume":"359","author":"de Kretser","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/db10-1493","article-title":"Activin a levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin a on inflammation","volume":"60","author":"Andersen","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jacc.2004.03.069","article-title":"Potential anti-inflammatory role of activin a in acute coronary syndromes","volume":"44","author":"Smith","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cyto.2014.06.017","article-title":"Regulation and actions of activin a and follistatin in myocardial ischaemia-reperfusion injury","volume":"69","author":"Chen","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.metabol.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"H1415","DOI":"10.1152\/ajpheart.01048.2009","article-title":"Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction","volume":"298","author":"Tan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0140","doi-asserted-by":"crossref","first-page":"e27901","DOI":"10.1371\/journal.pone.0027901","article-title":"A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure","volume":"6","author":"Fukushima","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.05.002_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2008.10.027","article-title":"Relationship between activin a level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention","volume":"401","author":"Miyoshi","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2017.05.002_bb0150","first-page":"420","article-title":"Activin a predicts left ventricular remodeling and mortality in patients with ST-elevation myocardial infarction","volume":"32","author":"Lin","year":"2016","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.metabol.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1475-2840-12-126","article-title":"Interleukin-6 and activin a are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and B\u00e6rum cardiovascular diabetes (ABCD) cohort study","volume":"12","author":"Ofstad","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2017.05.002_bb0160","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1074\/jbc.M110.197079","article-title":"Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy","volume":"286","author":"Shimano","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.05.002_bb0165","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12265-012-9400-9","article-title":"Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes","volume":"5","author":"Panse","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.metabol.2017.05.002_bb0170","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.metabol.2015.09.001","article-title":"Irisin: a true, circulating hormone","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2017.05.002_bb0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.metabol.2016.07.002","article-title":"Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans","volume":"65","author":"Anastasilakis","year":"2016","journal-title":"Metabolism"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517301439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517301439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:57Z","timestamp":1758427977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517301439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":35,"alternative-id":["S0026049517301439"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.05.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}